期刊文献+

超声药物透入治疗晚期结肠癌的疗效 被引量:3

The efficacy of ultrasonic drug penetration in the advanced colon cancer
下载PDF
导出
摘要 目的:探讨超声药物透入治疗晚期结肠癌在促进胃肠道功能恢复中的治疗效果。方法:将102例晚期结肠癌患者随机分为实验组和对照组。两组综合治疗相同,实验组使用超声药物透入治疗,而对照组未使用,观测两组患者血清IL-35、miRNA-936、腹围变化、肠鸣音恢复、肛门排气排便等胃肠功能恢复情况以及住院时间。结果:实验组和对照组血清IL-35、miRNA-936变化、腹围变化在治疗后48h、72h、96h及120h以及两组的肠鸣音恢复时间比较均有统计学差异(P<0.05),而治疗后腹围变化在24h时以及住院时间两组比较无明显差异(P>0.05)。结论:超声药物透入治疗可促进晚期结肠癌患者肠鸣音恢复及排气排便,减轻腹胀,加快胃肠功能恢复。 Objective:To discuss ultrasound theraPy drug Penetration in advanced colorectal cancer. Methods:All 102 Patients with advanced colorectal cancer were randomly divided into exPerimental and control grouPs,treated by same comPrehensive treatment,the exPerimental grouP using ultrasound Penetration drug theraPy,while the control grouP did not use,and tested for serum IL -35,miRNA -936,abdominal circumference changes,restore bowel sounds,flatus bowel and other gastrointestinal function. Results:In exPerimental grouP and the control grouP,serum IL-35,miRNA-936 changes,changes in abdominal circumference 48h,72h,96h and 120h and bowel sounds recovery time were statistically significant(P0. 05). Conclusion:Ultrasound theraPy can Promote drug Penetration in Patients with ad-vanced colon cancer and bowel sounds recover exhaust defecation,reduce bloating and accelerate recovery of gastroin-testinal function.
作者 项涛 雷慧
出处 《现代肿瘤医学》 CAS 2015年第13期1866-1869,共4页 Journal of Modern Oncology
基金 广东省佛山市卫生局医学科研立项课题(编号:2014208)
关键词 IL-35 miRNA-936 超声 晚期结肠 治疗 药物透入 IL-35 miRNA-936 ultrasound advanced colon cancer treatment drug Penetration
  • 相关文献

参考文献16

  • 1Niedbala WW, Cai BL. IL - 35 is anovel cytokinewith therapeuticeffects against collagen - induced arthritisthrough the expansion ofregulatory T cells and suppression of Thl7 [ J ]. Eur J Immunol,2013,37(11) :3293.
  • 2Li X, Mai J,Virtue A, et al. IL - 35 is a novel responsive antiin-flammatory eytokine - a new system of categorizing antiinflammatorycytokines[ J]. PLoS One,2012,7(3) :e33628.
  • 3Colli son LW, Chaturvedi V,Henderson AL,et al. IL - 35 - medi-atedinduction of a potent regulatory T cell population[ J]. Nat Im-munol,2010 ,11 (12) :1093 -1101.
  • 4Chaturvedi V, Collison LW, Guy CS,et al. Cutting edge: Humanregulatory T cells require IL - 35 to mediate suppression and infec-tious tolerance[ J]. J Immunol,2011,186(12) :6661 -6666.
  • 5Wu XJ,Li Y,Liu D,et al. miR -27a as an oncogenic microRNA ofhepatitis Bvirus - related hepatocellular carcinoma[ J]. Asian PacCancer Prev,2013 ,14(2) :885 -889.
  • 6Li X,Zhang Y,Ding J,et al. Survival prediction of gastric cancer bya microRNA signature[ J] . Gut,2010,59(5) :579 -585.
  • 7Ueda T, Volinia S, Okumura H,et al. Relation between microRNAexpression and progression and prognosis of gastric cancer : ami-croRNA expression analysis[ J]. Lancet Oncol,2010,11 (2) : 136-146.
  • 8Tie J,Pan YfZhao L,et al. MiR2 218 inhibits invasi on and metas-tasis of gastric cancer by targeting the Robol receptor [ J ]. PLoSGenet,2010,6(3) :el000879.
  • 9Cho W,Shin J, Kim J, et al. miR - 372 regulates cell cycle and-apoptosis of human gastric cancer cell line through direct regulationof LATS2[J]. Molecules and Cells,2009,28(6) :521 -527.
  • 10Zhu,Shan X, Wang T,et al. miR2 181b modulates multidmg re-sistance by targeting BCL2 in human cancer cell lines [ J ]. Int JCancer,2010,127( 11) :2520 - 2529.

二级参考文献21

共引文献191

同被引文献21

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部